Recruiting
Phase 2

Teclistamab

Sponsor:

Abramson Cancer Center at Penn Medicine

Code:

NCT05932680

Conditions

Myeloma Multiple

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Off Drug Surveillance

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Abramson Cancer Center at Penn Medicine on 2024-10-15.